Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.

Staying vaccinated as recommended by doctors can help patients limit their risk of adverse cardiovascular events, according to a new consensus statement published in European Heart Journal.

While Kardium raised $250 million in an oversubscribed funding round, Field Medical raised $35 million. Both companies are focused on designing and developing new pulsed field ablation technologies to help treat challenging arrhythmias. 

The new study, based on 14 different clinical trials, highlights why so many care teams have already adopted the cusp overlap technique when implanting self-expanding TAVR valves.

According to Medtronic, its VitalFlow ECMO system was designed and developed with the user experience in mind. 

"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained. 

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 

The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

IRs criticized the CMS proposal, believing it could lead to excess morbidity and mortality in Medicare. 

Spectrum V8 and V6 infusion pumps may have accidentally had their software switched, which could result in underinfusion or a fluid overload. While no injuries have been reported, for safety the affected pumps need to be removed from where they are used and sold.